PediaNotes

Paroxysmal hypercyanotic Spells

4 min read

Definition and Epidemiology

  • AKA Paroxysmal hypercyanotic attacks, hypoxic spells, blue spells, or anoxic spells.
  • Acute emergency requiring prompt recognition and intervention.
  • Peak incidence between 2 and 6 months of age.
  • Frequent occurrence before 2 years of age.
  • Higher susceptibility in infants with mild resting cyanosis lacking homeostatic compensatory mechanisms (e.g., polycythemia).

Triggers and Precipitating Factors

  • Spontaneous and unpredictable onset.
  • Early morning occurrence immediately after awakening.
  • Vigorous crying, agitation, or exertion.
  • Feeding.
  • Dehydration, fever, or pain.

Pathophysiology

graph TD
    A[Triggers: Crying, Feeding, Fever, Dehydration] --> B[Increased Catecholamines / Peripheral Vasodilatation]
    B --> C[Infundibular Spasm]
    B --> D[Decreased Systemic Vascular Resistance]
    C --> E[Decreased Pulmonary Blood Flow]
    D --> F[Increased Right-to-Left Shunt via VSD]
    E --> F
    F --> G[Severe Systemic Hypoxemia]
    G --> H[Metabolic Acidosis]
    H --> I[Stimulation of Respiratory Center]
    I --> J[Hyperpnea / Increased Venous Return]
    J --> F
  • Acute decrease in pulmonary blood flow.
  • Increased right-to-left shunting across ventricular septal defect.
  • Infundibular spasm from increased circulating catecholamines.
  • Activation of right ventricular mechanoreceptors secondary to decreased systemic venous return.
  • Activation of left ventricular mechanoreceptors secondary to decreased pulmonary blood flow.
  • Peripheral vasodilatation causing severe fall in systemic vascular resistance.
  • Systemic hypoxia inducing severe metabolic acidosis.
  • Acidosis stimulating respiratory center causing hyperpnea.
  • Increased venous return from hyperpnea worsening right-to-left shunt (vicious cycle).

Clinical Features

  • Inconsolable crying, restlessness, and severe irritability.
  • Hyperpnea with deep and rapid breathing.
  • Absence of significant subcostal recession despite hyperpnea.
  • Progressive, deepening cyanosis.
  • Gasping respirations.
  • Disappearance or marked reduction of right ventricular outflow tract systolic ejection murmur.
  • Episode duration ranging from a few minutes to several hours.
  • Generalized weakness and sleep following brief episodes.

Differential Diagnosis of Cyanotic Episodes

  • Cyanotic breath-holding spells (forced expiration during crying, age 6 months to 5 years).
  • Pallid breath-holding spells (associated severe bradycardia, first 1-2 years of life).
  • Acrocyanosis (peripheral cyanosis with cold exposure, normal pink mucous membranes).
  • Respiratory disorders (variable partial pressure of oxygen, responsive to mechanical ventilation).
  • Central nervous system disorders (hypoxia reversed with artificial ventilation).
  • Persistent pulmonary hypertension of the newborn (improved hypoxia with hyperventilation).

Complications

  • Syncope or loss of consciousness.
  • Convulsions and seizures.
  • Cerebral thrombosis, central nervous system infarction, hemiplegia.
  • Intractable metabolic acidosis, shock, and respiratory failure.
  • Death.

Management

Immediate Interventions

Reduce SVR and oxygen

  • Knee-chest position on abdomen (increases systemic vascular resistance, increases systemic venous return).
  • Loosening of constrictive clothing.
  • Oxygen delivery via face mask or nasal cannula.

Calming the child

  • Calming and holding the infant.
  • Subcutaneous morphine (0.2 mg/kg).
  • Intramuscular ketamine (3-5 mg/kg).
  • Intranasal fentanyl or midazolam.

ACIDOSIS/dehydration correction

  • Intravenous fluid bolus (10 mL/kg dextrose normal saline).
  • Avoidance of premature, agitating blood draws.
  • Transcutaneous oxygen saturation monitoring.
  • Intravenous sodium bicarbonate (1-2 mEq/kg diluted 1:1 or in 10 mL/kg N/5 in 5% dextrose) for rapid metabolic acidosis correction.

Pharmacological Interventions (Refractory Spells)

BETA blockers

  • Intravenous beta-blockade for infundibular spasm reduction and heart rate control.
  • Intravenous propranolol (0.15-0.25 mg/kg given slowly, repeatable once in 15 minutes).
  • Intravenous metoprolol (0.1 mg/kg slowly over 5 minutes, maximum 3 doses, followed by 1-2 mcg/kg/min infusion).
  • Intravenous esmolol infusion.

VASOPRESSORS

  • Vasopressor administration for systemic vascular resistance augmentation and forced pulmonary blood flow.
  • Intravenous phenylephrine (5 mcg/kg bolus, 1-4 mcg/kg/min infusion).
  • Intravenous methoxamine (0.1-0.2 mg/kg) or intramuscular methoxamine (0.1-0.4 mg/kg).
  • Intravenous diazepam (0.2 mg/kg) or midazolam (0.1-0.2 mg/kg) for seizure management.

OTHERS

  • Neuromuscular blockade, elective intubation, and mechanical ventilation for persistent spells.
  • Preparation for palliative (e.g., Blalock-Taussig-Thomas shunt) or corrective surgery.

Post-Spell Care and Prevention

  • Careful neurological examination and central nervous system imaging for focal deficits.
  • Oral propranolol therapy (0.5-1.5 mg/kg every 6-8 hours) for resting saturation improvement and spell frequency reduction.
  • Therapeutic or prophylactic iron supplementation (if hemoglobin <12 g/dL) for relative anemia correction and stroke risk reduction.
  • Strict avoidance of dehydration.
  • Detailed echocardiography for disease morphology delineation.
  • Parental counseling regarding spell recurrence and precipitating factors (dehydration, fever, pain).
  • Expedited elective surgical repair.

Backlinks

Graph View